Winfield Associates’s Cigna CI Stock Holding History

Winfield Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-80	Closed	-$11K	–	716
2016 Q1	$11K	Buy	+80	New	+$11K	0.01%	306

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Winfield Associates's CI Position: Q2 2016 in Review

Winfield Associates sold out of Cigna (CI) in Q2 2016, closing a stake of 80 shares — an estimated $11K sold.

Winfield Associates first reported a position in CI in Q1 2016 and held it in 1 quarter. The position peaked at $11K in Q1 2016. 711 funds tracked by Wall St. Rank hold CI as of Q2 2016.

Winfield Associates reported no remaining Cigna position as of Q2 2016 after selling out during the quarter.
Winfield Associates sold 80 Cigna shares in Q2 2016, an estimated $11K.
Winfield Associates first reported a position in Cigna in Q1 2016 and held it in 1 quarter.
Winfield Associates's Cigna position peaked at $11K in Q1 2016.
711 funds tracked by Wall St. Rank held Cigna as of Q2 2016.

Based on Winfield Associates's 13F filing for Q2 2016, filed 15 Aug 2016.